06:10 AM EDT, 07/12/2026 (MT Newswires) -- Moody's maintained Bayer's (BAYN.F) senior unsecured rating at Baa2 and revised the outlook to stable from negative in a July 10 report. The stable outlook underpins a "meaningful" decline in the German life science company's tail risk after the US Supreme Court's "positive" ruling on the weedkiller Roundup litigation during June. The rating agency also acknowledged greater visibility in Bayer's liquidity and legal funding after its 3 billion-euro minority equity transaction. At the same time, the rating affirmation is based on Bayer's debt reduction plans, "resilient" operations across pharmaceuticals and consumer health, and expectations for a steady rebound in crop science.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.